CERO
Income statement / Annual
Last year (2024), CERo Therapeutics Holdings, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, CERo Therapeutics Holdings, Inc.'s net income was -$11.09 M.
See CERo Therapeutics Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.16 M
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$7.08 M
|
$0.00
|
$9.85 M
|
$9.14 M
|
| General & Administrative Expenses |
$9.12 M
|
$2,892.94
|
$2.13 M
|
$2.48 M
|
| Selling & Marketing Expenses |
$0.00
|
$2.89 M
|
$715,763.00
|
-$2.23 M
|
| Selling, General & Administrative Expenses |
$9.12 M
|
$2.89 M
|
$2.84 M
|
$251,705.00
|
| Other Expenses |
$0.00
|
$40,050.00
|
-$64,050.00
|
-$80,320.00
|
| Operating Expenses |
$16.20 M
|
$2.93 M
|
$2.91 M
|
$332,026.00
|
| Cost And Expenses |
-$16.20 M
|
$2.93 M
|
$2.91 M
|
$332,030.00
|
| Interest Income |
$0.00
|
$491,571.00
|
$142,115.00
|
$986,711.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.16 M
|
$2,932.99
|
$1.07 M
|
$735,473.00
|
| EBITDA |
-$7.14 M |
-$2.44 M |
-$68,577.00 |
-$332,030.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$5.11 M
|
$491,571.00
|
$2.84 M
|
$99,081.00
|
| Income Before Tax |
-$11.09 M
|
-$2.44 M
|
-$68,577.00
|
-$332,415.00
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$94,819.00
|
$599,159.00
|
-$16,868.00
|
| Net Income |
-$11.09 M
|
-$2,536.23
|
-$667,736.00
|
-$315,547.00
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
| EPS |
-0.22 |
-0.0001 |
-0.0329 |
-0.0137 |
| EPS Diluted |
-0.22 |
-0.0001 |
-0.0329 |
-0.0137 |
| Weighted Average Shares Out |
$2.42 M
|
$19.58 M
|
$20.31 M
|
$22.98 M
|
| Weighted Average Shares Out Diluted |
$2.42 M
|
$19.59 M
|
$20.31 M
|
$22.98 M
|
| Link |
|
|
|
|
